New York, USA – February 21, 2022 – According to a report published in September, 2021 on preclinical CRO market, the global preclinical CRO market size was valued at USD 4.5 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2021 to 2028, which once again reflects the necessity and significance of preclinical development during the entire process of moving a new drug from design to production.
To establish the efficacy and safety of a drug candidate, the professional team from Creative Biolabs is capable of acquiring sufficient and detailed information through a wide variety of interlinked studies, including target validation, hit identification, lead validation, safety assessment and efficacy evaluation.
• Target Validation
As crucial as the door to drug discovery, target validation is the first step which involves a sequence of physiological, pathological and pharmacological evaluations. It aims to determine whether molecular targets are directly involved in the disease process and whether they are druggable. Therefore, before starting to develop drug candidates against the diseases and evaluating whether the drug works, the role of targets must be clearly defined. Creative Biolabs applies various techniques to provide powerful data on target identification and verification, including but not limited to the following:
*Sequencing Services
*Computer-Aided Target Validation Services
*Structure Determination
*Gene Manipulation
*In Vitro Functional Analysis
*In Vivo Functional Analysis
• Toxicological Studies
Drug-induced toxicity is the key reason for drug failure, so preclinical toxicology studies are essential in enabling the translation of findings from the laboratory to the clinic, and should be conducted thoroughly at an early stage. Creative Biolabs designs operative and rigorous methods to evaluate and minimize the potential for side effects and toxicities of new drug candidates both qualitatively and quantitatively to help the investigated candidates obtain market approval.
“Based on credible evidence, we can tell if a drug is ready to move into clinical trials,” said a technician from Creative Biolabs.
Explore more detailed information about target validation and toxicological studies at https://dataverify.creative-biolabs.com.
About Creative Biolabs
Guided by the values of responsibility, collaboration, and quality, Creative Biolabs prides itself on offering professional, efficient, integrated and customized preclinical development services for clients all over the world, and endeavors to accelerate drug discovery processes and improve the success rate of projects.
Media ContactCompany Name: Creative BiolabsContact Person: Candy SwiftEmail: Send EmailPhone: 1-631-830-6441Country: United StatesWebsite: https://dataverify.creative-biolabs.com
